381 related articles for article (PubMed ID: 18851925)
1. Dyskinesia-induced postural instability in Parkinson's disease.
Armand S; Landis T; Sztajzel R; Burkhard PR
Parkinsonism Relat Disord; 2009 Jun; 15(5):359-64. PubMed ID: 18851925
[TBL] [Abstract][Full Text] [Related]
2. Levodopa effect upon functional balance of Parkinson's disease patients.
Nova IC; Perracini MR; Ferraz HB
Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
[TBL] [Abstract][Full Text] [Related]
3. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
4. Onset and spread of dyskinesias and motor symptoms in Parkinson's disease.
Fabbrini G; Defazio G; Colosimo C; Suppa A; Bloise M; Berardelli A
Mov Disord; 2009 Oct; 24(14):2091-6. PubMed ID: 19691126
[TBL] [Abstract][Full Text] [Related]
5. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
6. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
Goetz CG; Damier P; Hicking C; Laska E; Müller T; Olanow CW; Rascol O; Russ H
Mov Disord; 2007 Jan; 22(2):179-86. PubMed ID: 17094088
[TBL] [Abstract][Full Text] [Related]
7. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease.
Bloem BR; Beckley DJ; van Dijk JG; Zwinderman AH; Remler MP; Roos RA
Mov Disord; 1996 Sep; 11(5):509-21. PubMed ID: 8866492
[TBL] [Abstract][Full Text] [Related]
8. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
[TBL] [Abstract][Full Text] [Related]
9. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
[TBL] [Abstract][Full Text] [Related]
10. Balance in Parkinson's disease under static and dynamic conditions.
Nardone A; Schieppati M
Mov Disord; 2006 Sep; 21(9):1515-20. PubMed ID: 16817196
[TBL] [Abstract][Full Text] [Related]
11. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Zesiewicz TA; Sullivan KL; Maldonado JL; Tatum WO; Hauser RA
Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135
[TBL] [Abstract][Full Text] [Related]
12. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
Liu X; Carroll CB; Wang SY; Zajicek J; Bain PG
J Neurosci Methods; 2005 May; 144(1):47-52. PubMed ID: 15848238
[TBL] [Abstract][Full Text] [Related]
13. Effect of medication and STN-DBS on postural control in subjects with Parkinson's disease.
Nantel J; McDonald JC; Bronte-Stewart H
Parkinsonism Relat Disord; 2012 Mar; 18(3):285-9. PubMed ID: 22130147
[TBL] [Abstract][Full Text] [Related]
14. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
Gour J; Edwards R; Lemieux S; Ghassemi M; Jog M; Duval C
Brain Res Bull; 2007 Sep; 74(1-3):66-74. PubMed ID: 17683791
[TBL] [Abstract][Full Text] [Related]
15. Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks.
Keijsers NL; Horstink MW; Gielen SC
Mov Disord; 2003 Jan; 18(1):70-80. PubMed ID: 12518302
[TBL] [Abstract][Full Text] [Related]
16. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
Fenney A; Jog MS; Duval C
Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
[TBL] [Abstract][Full Text] [Related]
17. Assessment of postural control in patients with Parkinson's disease: sway ratio analysis.
Błaszczyk JW; Orawiec R
Hum Mov Sci; 2011 Apr; 30(2):396-404. PubMed ID: 20800915
[TBL] [Abstract][Full Text] [Related]
18. Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease.
Mann RK; Edwards R; Zhou J; Jog M; Duval C
Clin Neurol Neurosurg; 2010 Jun; 112(5):392-9. PubMed ID: 20206438
[TBL] [Abstract][Full Text] [Related]
19. Identification of distinct characteristics of postural sway in Parkinson's disease: a feature selection procedure based on principal component analysis.
Rocchi L; Chiari L; Cappello A; Horak FB
Neurosci Lett; 2006 Feb; 394(2):140-5. PubMed ID: 16269212
[TBL] [Abstract][Full Text] [Related]
20. Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
Chastan N; Do MC; Bonneville F; Torny F; Bloch F; Westby GW; Dormont D; Agid Y; Welter ML
Mov Disord; 2009 Jan; 24(2):188-95. PubMed ID: 18973252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
